M. Kamata

发表

Effectiveness of Milnacipran for the Treatment of Chronic Pain: A Case Series

H. Higuchi, M. Kamata, Hitoshi Takahashi, 2004, Clinical neuropharmacology.

Efficacy of milnacipran in the treatment of chronic pain syndromes

K. Otani, A. Suzuki, H. Higuchi, 2010, International journal of psychiatry in clinical practice.

Milnacipran for the treatment of chronic pain

H. Higuchi, M. Kamata, Hitoshi Takahashi, 2003, Human psychopharmacology.

Parental overprotection increases interpersonal sensitivity in healthy subjects.

K. Otani, A. Suzuki, M. Kamata, 2009, Comprehensive psychiatry.

Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea.

H. Higuchi, Keizo Yoshida, Tetsuo Shimizu, 2003, The Journal of neuropsychiatry and clinical neurosciences.

Dysfunctional Parenting Styles Increase Interpersonal Sensitivity in Healthy Subjects

K. Otani, A. Suzuki, M. Kamata, 2009, The Journal of nervous and mental disease.

Remarkable effect of milnacipran in the treatment of Japanese major depressive patients

H. Higuchi, Keizo Yoshida, Tetsuo Shimizu, 2002, Human psychopharmacology.

Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.

Y. Sugawara, H. Higuchi, Keizo Yoshida, 2005, Clinical neuropharmacology.

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.

H. Higuchi, Keizo Yoshida, M. Kamata, 2005, Psychiatry and clinical neurosciences.

Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

K. Itoh, Toshio Suzuki, K. Otani, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effect of single intracerebroventricular injection of α-interferon on monoamine concentrations in the rat brain

H. Higuchi, Keizo Yoshida, M. Kamata, 2000, European Neuropsychopharmacology.

Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression

K. Nishimura, H. Higuchi, Keizo Yoshida, 2017, Neuropsychiatric disease and treatment.

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

C. Nemeroff, K. Itoh, Toshio Suzuki, 2010, The American journal of psychiatry.

Relationship Between Leukocyte Telomere Length and Personality Traits in Healthy Subjects

K. Goto, K. Otani, A. Suzuki, 2015, European Psychiatry.

The brain‐derived neurotrophic factor Val66Met polymorphism modulates the effects of parental rearing on personality traits in healthy subjects

K. Goto, K. Otani, A. Suzuki, 2011, Genes, brain, and behavior.

Remarkable effect of milnacipran, a serotonin–noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports

H. Higuchi, Keizo Yoshida, M. Kamata, 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Relationship of the 24-item Dysfunctional Attitude Scale with the Temperament and Character Inventory in healthy subjects

K. Otani, A. Suzuki, M. Kamata, 2013, Nordic journal of psychiatry.

Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms

C. Nemeroff, K. Itoh, Toshio Suzuki, 2004 .

Association between -1438G/A Promoter Polymorphism in the 5-HT2A Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder

Tetsuo Shimizu, Kunihiko Itoh, Hisashi Higuchi, 2002, Neuropsychobiology.

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine

N. Ozaki, K. Itoh, Toshio Suzuki, 2007, Journal of psychopharmacology.

The −67 A/T promoter polymorphism in the dopamine transporter gene affects personality traits of Japanese healthy females

K. Goto, K. Otani, A. Suzuki, 2009, Behavioural Brain Research.

Functional polymorphism of the GTP cyclohydrolase 1 gene affects the personality trait of novelty seeking in healthy subjects

K. Goto, K. Otani, A. Suzuki, 2011, Neuroscience Letters.

Association study between a functional polymorphism of tyrosine hydroxylase gene promoter and personality traits in healthy subjects

K. Goto, K. Otani, A. Suzuki, 2010, Behavioural Brain Research.

No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population.

K. Itoh, Toshio Suzuki, H. Higuchi, 2007, Biological & pharmaceutical bulletin.

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

K. Itoh, H. Takahashi, T. Shimizu, 2002, Psychiatry Research.

The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats 1 Presented at the XXth Collegium Internationale Neuro-Psychopharmacologicum Congress, 1996. 1

Y. Hishikawa, T. Shimizu, H. Higuchi, 1999, European Neuropsychopharmacology.

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients

K. Itoh, Toshio Suzuki, K. Otani, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Monoamine Oxidase A Gene Polymorphism, 5-HT2A Receptor Gene Polymorphism and Incidence of Nausea Induced by Fluvoxamine

Tetsuo Shimizu, Kunihiko Itoh, Hisashi Higuchi, 2003, Neuropsychobiology.

Parental overprotection increases sociotropy with gender specificity in parents and recipients.

K. Otani, A. Suzuki, M. Kamata, 2012, Journal of affective disorders.

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression

H. Higuchi, Keizo Yoshida, M. Kamata, 2009, Neuropsychiatric disease and treatment.

Association between disease severity according to "MN criteria" and 30-day mortality in patients with Clostridioides difficile infection.

M. Kamata, H. Ishii, K. Matsuo, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients

H. Higuchi, Keizo Yoshida, M. Kamata, 2009, Neuropsychiatric disease and treatment.

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients

H. Higuchi, Keizo Yoshida, M. Kamata, 2007 .

Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.

J. Ishigooka, H. Higuchi, Keizo Yoshida, 2006, The Journal of clinical psychiatry.

Influence of the tyrosine hydroxylase val81met polymorphism and catechol‐O‐methyltransferase val158met polymorphism on the antidepressant effect of milnacipran

N. Ozaki, K. Itoh, Toshio Suzuki, 2008, Human psychopharmacology.

Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder.

K. Otani, A. Suzuki, H. Higuchi, 2011, Journal of affective disorders.

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

Kunihiko Ito, Toshio Suzuki, H. Higuchi, 2002, European Neuropsychopharmacology.

Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females

K. Goto, K. Otani, A. Suzuki, 2008, Neuroscience Letters.

Association study between the −1021C/T polymorphism of the dopamine-β-hydroxylase gene promoter and personality traits in healthy subjects

K. Goto, K. Otani, A. Suzuki, 2009, Neuroscience Letters.

Bcl1 Polymorphism of the Glucocorticoid Receptor Gene and Treatment Response to Milnacipran and Fluvoxamine in Japanese Patients with Depression

J. Ishigooka, Toshio Suzuki, H. Higuchi, 2014, Neuropsychobiology.

Milnacipran plasma levels and antidepressant response in Japanese major depressive patients

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 2003, Human psychopharmacology.

Predictors of antidepressant response to fluvoxamine obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale for major depressive disorders in Japanese patients

K. Otani, H. Higuchi, Keizo Yoshida, 2008, Psychiatry and clinical neurosciences.

Serum Brain-derived Neurotrophic Factor Levels Following Electroconvulsive Therapy in Treatment-resistant Depressed Patients

H. Higuchi, M. Kamata, Oga Sasaki, 2015 .

Panic attacks in patients with chronic schizophrenia: A complication of long‐term neuroleptic treatment

Y. Hishikawa, H. Higuchi, M. Kamata, 1999, Psychiatry and clinical neurosciences.

Association study of the cytochrome P450 17 gene polymorphism with personality traits in healthy subjects

K. Goto, K. Otani, A. Suzuki, 2008, Behavioural Brain Research.

association between serotonin transporter polymorphisms (5-hTTlPr) and the MaDrs Dysphoria, retardation, and Vegetative subscale scores in the treatment of depression

K. Nishimura, H. Higuchi, Keizo Yoshida, 2017 .

Interaction effect between the BDNF Val66Met polymorphism and parental rearing for interpersonal sensitivity in healthy subjects

K. Goto, K. Otani, A. Suzuki, 2012, Psychiatry Research.

The brain‐derived neurotrophic factor Val66Met polymorphism modulates the effects of parental rearing on personality traits in healthy subjects

A. Suzuki, M. Kamata, Y. Matsumoto, 2011, Genes, brain, and behavior.

No predictors of antidepressant patient response to milnacipran were obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale in Japanese patients with major depressive disorders

K. Otani, H. Higuchi, Keizo Yoshida, 2008, Psychiatry and clinical neurosciences.

Response Rate Obtained Using Milnacipran Depending on the Severity of Depression in the Treatment of Major Depressive Patients

Y. Sugawara, H. Higuchi, Keizo Yoshida, 2006, Clinical neuropharmacology.

Association study between a functional polymorphism of FK506-binding protein 51 (FKBP5) gene and personality traits in healthy subjects

Y. Hozumi, K. Goto, K. Otani, 2010, Neuroscience Letters.

Augmentation with olanzapine in TCA‐refractory depression with melancholic features: a consecutive case series

J. Ishigooka, H. Higuchi, Keizo Yoshida, 2008, Human psychopharmacology.

Increased Body Mass Index Associated With Increased Harm Avoidance and Decreased Self-Directedness in Japanese Women

K. Otani, A. Suzuki, M. Kamata, 2009, The Journal of nervous and mental disease.